Perception of dyspnea and treatment adherence in asthmatic patients

Archivos de Bronconeumologia

Volumn 44, Issue 9, 2008, Pages 459-463

  Martínez Moragón, Eva ^a,d   Perpiñá, Miguel ^b   Fullana, Javier ^a   Macián, Vicente ^b   Lloris, Amparo ^b   Belloch, Amparo ^c  

^a HOSPITAL DE SAGUNTO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d NONE   (Spain)

Author keywords

Asthma; Dyspnea; Perception; Treatment adherence

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTAMINE PHOSPHATE; SALBUTAMOL;

ADULT; ANXIETY; ARTICLE; ASTHMA; BRONCHUS OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PATIENT COMPLIANCE; RATING SCALE; SPIROMETRY; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; ASTHMA; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE;

EID: 55049096748     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1157/13126089     Document Type: Article

References (27)

1. Rabe KF, Vermiere PA, Soriano JB, Maier WC. Clinical management of asthma in 1999; the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
2. López Viña A, Cimas JE, Díaz Sánchez C, Coria G, Vegazo O, Picado C. A comparison of primary care physicians and pneumologist in the management of asthma in Spain: ASES study. Respir Med. 2003;97:872-81.
3. Soriano JB, Rabe KF, Vermiere PA. Predictors of poor asthma control in European adults. J Asthma. 2003;40:803-13.
4. Bender BG, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem? Ann Allergy Asthma Immunol. 1997;79:177-86.
5. López Viña A. Actitudes para fomentar el cumplimiento terapéutico en el asma. Arch Bronconeumol. 2005;41:334-40.
6. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004;4:191-5.
7. Bender BG, Long A, Parasuraman B, Tran ZV. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol. 2007;98:322-8.
8. Corsico AG, Cazzoletti L, De Marco R, Janson C, Jarvis D, Zoia MC, et al. Factors affecting adherence to asthma treatment in an international cohort of young and middle-aged adults. Respir Med. 2007;101:1363-7.
9. Martínez Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez Francés ME. Percepción de disnea de los pacientes con asma durante la broncoconstricción aguda. Arch Bronconeumol. 2003;39:67-73.
10. Magadle R, Berar-Yanay N, Weiner P. The risk of hospitalization and near-fatal asthma in relation to the perception of dyspnea. Chest. 2002;121:329-33.
11. Boulet LP, Deschessness F, Turcotte H, Gignac F. Near fatal asthma: clinical and physiologic features, perception of bronchoconstriction and psychogenic profile. J Allergy Clin Inmunol. 1991; 88:838-46.
12. López-Viña A, Agüero-Balbín R, Aller-Álvarez JL, Bazús T, de Diego A, García-Cosio FB, et al. Normativa para el asma de control difícil. Arch Bronoconeumol. 2005;41:513-23.
13. Martínez Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez Francés ME. Concordancia entre la percepción de disnea del asmático durante la obstrucción aguda y crónica. Arch Bronconeumol. 2005;41:371-5.
14. Martínez Moragón E, Perpiñá M, Belloch A, Serra B, Lloris A, Macián V. Evolución temporal de la percepción exagerada de disnea en los pacientes con asma. Arch Bronconeumol. 2006;42:120-4.
15. Martínez Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez Francés ME. Determinants of dyspnea in patients with different grades of stable asthma. J Asthma. 2003;40:375-82.
16. Martínez Moragón E, Perpiñá M, Belloch A. ¿Influye la experiencia en la percepción de disnea? Arch Bronconeumol. 2006;42:171-4.
17. Global Iniciative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. Bethesda: National Institutes of Health; 1996.
18. Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M. Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med. 1999;93:88-94.
19. Spielberger CD, Gorsuch RL, Lushene E. STAI, manual for the State-Trait Anxiety Inventory (self evaluation questionnaire). Palo Alto; Consulting Psychologists Press; 1970.
20. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York: Guilford Press; 1979.
21. Sanchis J, Casán P, Castillo J, González N, Palenciano L, Roca J. Normativa para la práctica de la espirometría forzada. Arch Bronconeumol. 1989;25:132-42.
22. Boulet LP, Leblanc P, Turcotte H. Perception scoring of induced bronchoconstriction as an index of awareness of asthma symptoms. Chest. 1994;105:1430-3.
23. Cockroft DW, Killian DN, Mellon JA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1997;7:235-43.
24. Borg GAV. Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982;14:377-81.
25. Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med. 2001;95:37-9.
26. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149:S69-S76.
27. Ohm R, Aaronson S. Symptom perception and adherence to asthma controller medications. J Nurs Scholars. 2006;38:292-7.